The narrow road to the indigenous rotavirus vaccine

Abstract

The common dream of fighting this disease led to a joint venture under INDO-US Vaccine Action Program (VAP) of Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India and Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA. Active collaboration of basic researchers, clinicians, and epidemiologist during initial phase of development; and close coordination between governmental, nongovernmental, and funding organizations and manufacturing industry; in the later part, was crucial for scaling up the vaccine for clinical efficacy trials.